Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Pirfenidone by Avalyn Pharma for Pulmonary Fibrosis: Likelihood of Approval
Pirfenidone is under clinical development by Avalyn Pharma and currently in Phase II for Pulmonary Fibrosis. According to GlobalData, Phase...
Data Insights
Pirfenidone by Yungjin Pharm for Idiopathic Pulmonary Fibrosis: Likelihood of Approval
Pirfenidone is under clinical development by Yungjin Pharm and currently in Phase I for Idiopathic Pulmonary Fibrosis. According to GlobalData,...